High Tower Advisors, LLC Fulgent Genetics, Inc. Transaction History

High Tower Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$28.52 - $40.7 $164,959 - $235,408	5,784 New	5,784 $214,000
Q4 2022 Feb 08, 2023	BUY	$29.23 - $40.28 $40,512 - $55,828	1,386 Added 18.69%	8,800 $262,000
Q3 2022 Nov 09, 2022	SELL	$37.92 - $63.74 $8,228 - $13,831	-217 Reduced 2.84%	7,414 $279,000
Q2 2022 Aug 10, 2022	SELL	$47.98 - $62.75 $2,255 - $2,949	-47 Reduced 0.61%	7,631 $413,000
Q1 2022 May 12, 2022	BUY	$49.85 - $96.11 $4,336 - $8,361	87 Added 1.15%	7,678 $476,000
Q4 2021 Feb 10, 2022	BUY	$77.3 - $105.0 $285,932 - $388,395	3,699 Added 95.04%	7,591 $770,000
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $70,228 - $103,996	-938 Reduced 19.42%	3,892 $349,000
Q2 2021 Aug 06, 2021	SELL	$66.8 - $100.45 $54,776 - $82,369	-820 Reduced 14.51%	4,830 $446,000
Q1 2021 May 10, 2021	SELL	$59.3 - $183.85 $114,804 - $355,933	-1,936 Reduced 25.52%	5,650 $545,000
Q4 2020 Feb 10, 2021	BUY	$31.01 - $52.1 $235,241 - $395,230	7,586 New	7,586 $395,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.